Kursprognose für Dr Reddy's Laboratories Ltd (RDY)RDYDr Reddy's Laboratories Ltd

Alphio's RDY stock price prediction model matches the current Dr Reddy's Laboratories Ltd tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $13.42 (+1.61%). The 1-week path is $14.39 (+8.96%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Dr. Reddy's Laboratories Ltd is a good buy right now due to its current price of $13.21 being below the analyst price target of $14.80, indicating a potential upside of 11.99%. Additionally, the stock's RSI is at 72.641, suggesting it is nearing overbought territory but still has momentum. The forward P/E ratio is 27.027, which is reasonable given the company's growth potential, especially with the recent launch of its generic Sugammadex injection expected to increase market share significantly. However, a key risk is the declining gross margin, which fell to 44.82% in the latest quarter, indicating potential pressure on profitability.

Dr Reddy's Laboratories Ltd (RDY) last closed at $13.21, losing -0.15%. These facts feed the 1-day and 1-week RDY price prediction above.